Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeneSight Psychotropic test in treatment-naïve MDD
NCT03537547Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- May 2018
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Hamilton Rating Scale for Depression change score at 8 weeks. Started May 2018; status: terminated.
Beyond the preview
Go deeper on NCT03537547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537547.